Table 1.
Regulon | # of genes in regulon | Postulated physiological function | Best adjusted p-value* |
---|---|---|---|
1 | 332 | Plasma membrane part | 8.7 × 10−7 |
2 | 203 | Immune response, signal transducer activity | 2.2 × 10−35 |
3 | 193 | Structural constitute of ribosome, translation elongation | 1.5 × 10−140 |
4 | 120 | Regulation of actin cytoskeleton organization, protein binding | 2.9 × 10−11 |
5 | 95 | DNA replication, cell cycle process, cell division, protein binding | 3.4 × 10−51 |
6 | 84 | Cell adhesion, extracellular matrix, cytoskeleton organization and biogenesis | 2.0 × 10−9 |
7 | 69 | Proteasome complex, anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process, threonine-type endopeptidase activity | 2.2 × 10−9 |
8 | 48 | Not clear, protein amino acid phosphorylation | 1,5 × 10−2 |
9 | 46 | Cell communication, signal transduction, immune response, T-cell receptor complex | 2.2 × 10−16 |
10 | 39 | Immunoglobulin, antigen binding, immune response | 1.4 × 10−10 |
11 | 36 | Mitochondrial inner membrane transporter, oxidation reduction, respiratory electron transport chain, nucleotide metabolic process | 6.6 × 10−29 |
12 | 35 | Organ development, development process, lymphocyte mediated immunity, ion transport, cell adhesion, extracellular organization and biogenesis | 1.0 × 10−19 |
13 | 27 | Nuclear part, macromolecular complex assembly, mRNA transport, protein import into nucleus, biopolymer biosynthetic process | 2.8 × 10−8 |
14 | 25 | GTPase activity | 1.6 × 10−4 |
15 | 24 | Muscle cell development, muscle contraction, regulation of muscle contraction | 1.2 × 10−24 |
16 | 22 | Immune response, defense response | 2.8 × 10−5 |
17 | 19 | Sphingolipid catabolic process, lysosome, vacuole | 1.6 × 10−5 |
18 | 18 | NADH dehydrogenase activity, oxidation reduction, phosphorus metabolic process, purine nucleotide metabolic process, mitochondrial envelope | 2.4 × 10−24 |
19 | 16 | NADPH metabolic process, polyamine metabolic process, V-type ATPase | 2.7 × 10−5 |
20 | 16 | Oncosis, nuclear part | 2.4 × 10−3 |
21 | 15 | Regulation of transcription | 4.2 × 10−3 |
22 | 15 | Not clear, nitrogen fixation | 3.7 × 10−3 |
23 | 14 | RNA splicing, splicesomal complex, nuclear speck | 4.2 × 10−7 |
24 | 14 | Response to cAMP, negative regulation of myeloid cell differentiation, regulation of gene expression, methylation, transcription, protein kinase cascade | 4.7 × 10−7 |
25 | 14 | Not clear, pentose-phosphate shunt, non-oxidative branch | 5.5 × 10−3 |
26 | 14 | Cysteine-type endopetidase activity, protein kinase cascade, PML body | 2.1 × 10−4 |
27 | 14 | MHC class II protein complex, antigen processing and presentation | 1.3 × 10−24 |
28 | 12 | Vesicle coating_mRNA splicing, transportation | 3.8 × 10−4 |
29 | 12 | RNA splicing, spliceosomal complex, nuclear speck | 1.8 × 10−11 |
30 | 12 | Nuclear speck | 1.4 × 10−4 |
31 | 12 | Not Clear, polytene chromosome | 4.7 × 10−3 |
32 | 12 | Calcium-independent cell-cell adhesion, cell-cell junction | 8.2 × 10−7 |
33 | 11 | Cell cycle, negative regulation of ligase activity | 2.0 × 10−7 |
34 | 11 | Protein export from nucleus, splicesomal snRNP biogenesis, ribonucleoprotein complex | 2.3 × 10−5 |
35 | 11 | Translation | 1.6 × 10−5 |
36 | 11 | UDP catabolic process, MLL5-L complex | 1.0 × 10−3 |
37 | 11 | Response to hormone stimulus | 8.9 × 10−4 |
38 | 11 | Axon target recognition, neuron projection | 4.7 × 10−6 |
39 | 10 | mRNA processing, RNA splicing, nuclear body | 3.0 × 10−8 |
40 | 10 | Gene expression, U2 SnRNP | 2.0 × 10−3 |
Best adjusted p-value is the term for the lowest adjusted p-value associated with the most overrepresented GO term among all GO terms. The p-value adjustment is implemented using the Bonfferoni method, in R package “GOHyperGAll” [12].